Beam Therapeutics Inc. (BEAM)

NASDAQ: BEAM · Real-Time Price · USD

21.90

-0.29 (-1.31%)

At close: Mar 30, 2026, 4:00 PM EDT

21.37

-0.53 (-2.42%)

After-hours: Mar 30, 2026, 7:37 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Biotechnology (Startups)	139.74M	63.52M	377.71M	60.92M	51.84M
Biotechnology (Startups) Growth	120.01%	-83.18%	520.01%	17.51%	215916.67%
Total	139.74M	63.52M	377.71M	60.92M	51.84M
Total Growth	120.01%	-83.18%	520.01%	17.51%	215916.67%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States	139.74M	63.52M	377.71M	60.92M	51.84M
United States Growth	120.01%	-83.18%	520.01%	17.51%	215916.67%
Total	139.74M	63.52M	377.71M	60.92M	51.84M
Total Growth	120.01%	-83.18%	520.01%	17.51%	215916.67%

Source: S&P Global Market Intelligence.